In vitro and in vivo SAR of pyrido[3,4- d]pyramid-4-ylamine based mGluR1 antagonists
SAR and CNS penetration of a series of novel mgluR1 antagonists is described. The multiple of the unbound K i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is given. The SAR of a series of novel pyrido[3,4- d]pyramid-4-ylamine m...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2009-04, Vol.19 (8), p.2190-2194 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2194 |
---|---|
container_issue | 8 |
container_start_page | 2190 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 19 |
creator | Mantell, Simon J. Gibson, Karl R. Osborne, Simon A. Maw, Graham N. Rees, Huw Dodd, Peter G. Greener, Ben Harbottle, Gareth W. Million, William A. Poinsard, Cedric England, Steven Carnell, Pauline Betts, Alison M. Monhemius, Russell Prime, Rebecca L. |
description | SAR and CNS penetration of a series of novel mgluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is given.
The SAR of a series of novel pyrido[3,4-
d]pyramid-4-ylamine mGluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is determined and the effect of structure on CNS penetration examined. |
doi_str_mv | 10.1016/j.bmcl.2009.02.106 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67111523</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X09002728</els_id><sourcerecordid>67111523</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-fba1ebc00721b87c8be7dc6a86dc626a4aec2228de1e1d49a38b4cd2d3732a13</originalsourceid><addsrcrecordid>eNqFkEFrFDEUx4Modlv9Ah4kF3vqrHlJJpMBL6VoLRSEugdBJGSSN5JlZrImswv77c2wi94UQpL3-P0fyY-QN8DWwEC936670Q1rzli7Zrz01DOyAqlkJSSrn5MVaxWrdCu_XZDLnLeMgWRSviQX0HJdlliRzcNED2FOkdrJ07AUh0i_3j7R2NPdMQUfv4sbWVH_o1R2DL6S1XEolwlpZzN6Ot4P-yco-dn-jFPIc35FXvR2yPj6fF6RzaePm7vP1eOX-4e728fKSQ1z1XcWsHOMNRw63TjdYeOdslqVnSsrLTrOufYICF62VuhOOs-9aAS3IK7I9WnsLsVfe8yzGUN2OAx2wrjPRjUAUHPxX5CzmteiXkB-Al2KOSfszS6F0aajAWYW52ZrFudmcW4YLz1VQm_P0_fdiP5v5Cy5AO_OgM3ODn2ykwv5D8dBtNDo5T8fThwWZ4eAyWQXcHLoQ0I3Gx_Dv97xGy1qnnE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20525353</pqid></control><display><type>article</type><title>In vitro and in vivo SAR of pyrido[3,4- d]pyramid-4-ylamine based mGluR1 antagonists</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Mantell, Simon J. ; Gibson, Karl R. ; Osborne, Simon A. ; Maw, Graham N. ; Rees, Huw ; Dodd, Peter G. ; Greener, Ben ; Harbottle, Gareth W. ; Million, William A. ; Poinsard, Cedric ; England, Steven ; Carnell, Pauline ; Betts, Alison M. ; Monhemius, Russell ; Prime, Rebecca L.</creator><creatorcontrib>Mantell, Simon J. ; Gibson, Karl R. ; Osborne, Simon A. ; Maw, Graham N. ; Rees, Huw ; Dodd, Peter G. ; Greener, Ben ; Harbottle, Gareth W. ; Million, William A. ; Poinsard, Cedric ; England, Steven ; Carnell, Pauline ; Betts, Alison M. ; Monhemius, Russell ; Prime, Rebecca L.</creatorcontrib><description>SAR and CNS penetration of a series of novel mgluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is given.
The SAR of a series of novel pyrido[3,4-
d]pyramid-4-ylamine mGluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is determined and the effect of structure on CNS penetration examined.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2009.02.106</identifier><identifier>PMID: 19289283</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Analgesics ; Animals ; Biological and medical sciences ; Central nervous system ; Electromyography - methods ; Excitatory Amino Acid Antagonists - chemical synthesis ; Excitatory Amino Acid Antagonists - chemistry ; Excitatory Amino Acid Antagonists - pharmacology ; Glutamatergic system (aspartate and other excitatory aminoacids) ; Medical sciences ; mgluR1 ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Nociceptive pain ; Pain Measurement - drug effects ; Pain Measurement - methods ; Pharmacology. Drug treatments ; Rats ; Receptors, Metabotropic Glutamate - antagonists & inhibitors ; Receptors, Metabotropic Glutamate - physiology ; Structure-Activity Relationship</subject><ispartof>Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2190-2194</ispartof><rights>2009 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-fba1ebc00721b87c8be7dc6a86dc626a4aec2228de1e1d49a38b4cd2d3732a13</citedby><cites>FETCH-LOGICAL-c481t-fba1ebc00721b87c8be7dc6a86dc626a4aec2228de1e1d49a38b4cd2d3732a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2009.02.106$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21391781$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19289283$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mantell, Simon J.</creatorcontrib><creatorcontrib>Gibson, Karl R.</creatorcontrib><creatorcontrib>Osborne, Simon A.</creatorcontrib><creatorcontrib>Maw, Graham N.</creatorcontrib><creatorcontrib>Rees, Huw</creatorcontrib><creatorcontrib>Dodd, Peter G.</creatorcontrib><creatorcontrib>Greener, Ben</creatorcontrib><creatorcontrib>Harbottle, Gareth W.</creatorcontrib><creatorcontrib>Million, William A.</creatorcontrib><creatorcontrib>Poinsard, Cedric</creatorcontrib><creatorcontrib>England, Steven</creatorcontrib><creatorcontrib>Carnell, Pauline</creatorcontrib><creatorcontrib>Betts, Alison M.</creatorcontrib><creatorcontrib>Monhemius, Russell</creatorcontrib><creatorcontrib>Prime, Rebecca L.</creatorcontrib><title>In vitro and in vivo SAR of pyrido[3,4- d]pyramid-4-ylamine based mGluR1 antagonists</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>SAR and CNS penetration of a series of novel mgluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is given.
The SAR of a series of novel pyrido[3,4-
d]pyramid-4-ylamine mGluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is determined and the effect of structure on CNS penetration examined.</description><subject>Analgesics</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Central nervous system</subject><subject>Electromyography - methods</subject><subject>Excitatory Amino Acid Antagonists - chemical synthesis</subject><subject>Excitatory Amino Acid Antagonists - chemistry</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Glutamatergic system (aspartate and other excitatory aminoacids)</subject><subject>Medical sciences</subject><subject>mgluR1</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Nociceptive pain</subject><subject>Pain Measurement - drug effects</subject><subject>Pain Measurement - methods</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Receptors, Metabotropic Glutamate - antagonists & inhibitors</subject><subject>Receptors, Metabotropic Glutamate - physiology</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFrFDEUx4Modlv9Ah4kF3vqrHlJJpMBL6VoLRSEugdBJGSSN5JlZrImswv77c2wi94UQpL3-P0fyY-QN8DWwEC936670Q1rzli7Zrz01DOyAqlkJSSrn5MVaxWrdCu_XZDLnLeMgWRSviQX0HJdlliRzcNED2FOkdrJ07AUh0i_3j7R2NPdMQUfv4sbWVH_o1R2DL6S1XEolwlpZzN6Ot4P-yco-dn-jFPIc35FXvR2yPj6fF6RzaePm7vP1eOX-4e728fKSQ1z1XcWsHOMNRw63TjdYeOdslqVnSsrLTrOufYICF62VuhOOs-9aAS3IK7I9WnsLsVfe8yzGUN2OAx2wrjPRjUAUHPxX5CzmteiXkB-Al2KOSfszS6F0aajAWYW52ZrFudmcW4YLz1VQm_P0_fdiP5v5Cy5AO_OgM3ODn2ykwv5D8dBtNDo5T8fThwWZ4eAyWQXcHLoQ0I3Gx_Dv97xGy1qnnE</recordid><startdate>20090415</startdate><enddate>20090415</enddate><creator>Mantell, Simon J.</creator><creator>Gibson, Karl R.</creator><creator>Osborne, Simon A.</creator><creator>Maw, Graham N.</creator><creator>Rees, Huw</creator><creator>Dodd, Peter G.</creator><creator>Greener, Ben</creator><creator>Harbottle, Gareth W.</creator><creator>Million, William A.</creator><creator>Poinsard, Cedric</creator><creator>England, Steven</creator><creator>Carnell, Pauline</creator><creator>Betts, Alison M.</creator><creator>Monhemius, Russell</creator><creator>Prime, Rebecca L.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20090415</creationdate><title>In vitro and in vivo SAR of pyrido[3,4- d]pyramid-4-ylamine based mGluR1 antagonists</title><author>Mantell, Simon J. ; Gibson, Karl R. ; Osborne, Simon A. ; Maw, Graham N. ; Rees, Huw ; Dodd, Peter G. ; Greener, Ben ; Harbottle, Gareth W. ; Million, William A. ; Poinsard, Cedric ; England, Steven ; Carnell, Pauline ; Betts, Alison M. ; Monhemius, Russell ; Prime, Rebecca L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-fba1ebc00721b87c8be7dc6a86dc626a4aec2228de1e1d49a38b4cd2d3732a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Analgesics</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Central nervous system</topic><topic>Electromyography - methods</topic><topic>Excitatory Amino Acid Antagonists - chemical synthesis</topic><topic>Excitatory Amino Acid Antagonists - chemistry</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Glutamatergic system (aspartate and other excitatory aminoacids)</topic><topic>Medical sciences</topic><topic>mgluR1</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Nociceptive pain</topic><topic>Pain Measurement - drug effects</topic><topic>Pain Measurement - methods</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Receptors, Metabotropic Glutamate - antagonists & inhibitors</topic><topic>Receptors, Metabotropic Glutamate - physiology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mantell, Simon J.</creatorcontrib><creatorcontrib>Gibson, Karl R.</creatorcontrib><creatorcontrib>Osborne, Simon A.</creatorcontrib><creatorcontrib>Maw, Graham N.</creatorcontrib><creatorcontrib>Rees, Huw</creatorcontrib><creatorcontrib>Dodd, Peter G.</creatorcontrib><creatorcontrib>Greener, Ben</creatorcontrib><creatorcontrib>Harbottle, Gareth W.</creatorcontrib><creatorcontrib>Million, William A.</creatorcontrib><creatorcontrib>Poinsard, Cedric</creatorcontrib><creatorcontrib>England, Steven</creatorcontrib><creatorcontrib>Carnell, Pauline</creatorcontrib><creatorcontrib>Betts, Alison M.</creatorcontrib><creatorcontrib>Monhemius, Russell</creatorcontrib><creatorcontrib>Prime, Rebecca L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mantell, Simon J.</au><au>Gibson, Karl R.</au><au>Osborne, Simon A.</au><au>Maw, Graham N.</au><au>Rees, Huw</au><au>Dodd, Peter G.</au><au>Greener, Ben</au><au>Harbottle, Gareth W.</au><au>Million, William A.</au><au>Poinsard, Cedric</au><au>England, Steven</au><au>Carnell, Pauline</au><au>Betts, Alison M.</au><au>Monhemius, Russell</au><au>Prime, Rebecca L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro and in vivo SAR of pyrido[3,4- d]pyramid-4-ylamine based mGluR1 antagonists</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2009-04-15</date><risdate>2009</risdate><volume>19</volume><issue>8</issue><spage>2190</spage><epage>2194</epage><pages>2190-2194</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>SAR and CNS penetration of a series of novel mgluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is given.
The SAR of a series of novel pyrido[3,4-
d]pyramid-4-ylamine mGluR1 antagonists is described. The multiple of the unbound
K
i in cerebrospinal fluid necessary to give morphine like analgesic effects in an electromyograph pinch model in rodents is determined and the effect of structure on CNS penetration examined.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>19289283</pmid><doi>10.1016/j.bmcl.2009.02.106</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2009-04, Vol.19 (8), p.2190-2194 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_67111523 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Analgesics Animals Biological and medical sciences Central nervous system Electromyography - methods Excitatory Amino Acid Antagonists - chemical synthesis Excitatory Amino Acid Antagonists - chemistry Excitatory Amino Acid Antagonists - pharmacology Glutamatergic system (aspartate and other excitatory aminoacids) Medical sciences mgluR1 Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Nociceptive pain Pain Measurement - drug effects Pain Measurement - methods Pharmacology. Drug treatments Rats Receptors, Metabotropic Glutamate - antagonists & inhibitors Receptors, Metabotropic Glutamate - physiology Structure-Activity Relationship |
title | In vitro and in vivo SAR of pyrido[3,4- d]pyramid-4-ylamine based mGluR1 antagonists |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A12%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20and%20in%20vivo%20SAR%20of%20pyrido%5B3,4-%20d%5Dpyramid-4-ylamine%20based%20mGluR1%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Mantell,%20Simon%20J.&rft.date=2009-04-15&rft.volume=19&rft.issue=8&rft.spage=2190&rft.epage=2194&rft.pages=2190-2194&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2009.02.106&rft_dat=%3Cproquest_cross%3E67111523%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20525353&rft_id=info:pmid/19289283&rft_els_id=S0960894X09002728&rfr_iscdi=true |